Related Experiment Video

Updated: May 27, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Staying alive: defensive strategies in the BCL-2 family playbook

Sean P Cullen1, Conor M Henry, Seamus J Martin

  • 1Science Foundation Ireland, Laboratory for Molecular Cell Biology, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland.

Molecular Cell
|November 22, 2011
PubMed

Insights

Prosurvival BCL-2 proteins block apoptosis by inhibiting the BAX/BAK channel. Llambi et al. reveal two distinct inhibition modes that differ in response to repeated proapoptotic signals.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Biochemistry

Background:

  • The BCL-2 protein family plays a critical role in regulating apoptosis, the process of programmed cell death.
  • Prosurvival BCL-2 members, such as BCL-2 and BCL-XL, are known to inhibit apoptosis by preventing the activation of BAX and BAK.
  • The precise mechanisms by which prosurvival BCL-2 proteins repress the opening of the BAX/BAK channel remain a subject of intense research and debate.

Discussion:

  • This study investigates the functional mechanisms of apoptosis inhibition by prosurvival BCL-2 proteins.
  • The research identifies two distinct modes of BAX/BAK channel inhibition.
  • These modes exhibit differential responses when subjected to repeated challenges by BH3-only proteins, key regulators of apoptosis.

Key Insights:

  • Llambi et al. (2011) demonstrate that prosurvival BCL-2 proteins employ at least two different strategies to block apoptosis.
  • One mode involves direct repression of BAX/BAK channel opening, while the other may involve indirect mechanisms or different conformational states.
  • The differential behavior highlights the complexity of apoptosis regulation and the adaptability of prosurvival mechanisms.

Outlook:

  • Further elucidation of these inhibition modes could reveal novel therapeutic targets for diseases involving dysregulated apoptosis, such as cancer and neurodegenerative disorders.
  • Understanding the nuances of BCL-2 family interactions offers potential for developing drugs that selectively modulate apoptosis.
  • Future research should focus on the structural and dynamic aspects underlying these distinct inhibition modes.

More Related Videos

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling08:51

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling

Published on: June 25, 2015

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...